Loading…
Loading…
C3.ai (AI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Adv
Ping An Unveils Innovative AI Solutions in Healthcare, Insurance and Payments at WAIC 2026 PR Newswire HONG KONG
LOS ANGELES--(BUSINESS WIRE)---- $ai #AI--Arcadia Capital announced today the appointment of Jon Wesner as a Managing Director. Jon joins the firm's senior advisory team, expanding Arcadia Capital's coverage of tech and tech services companies and investors, driving global M&A and growth capital dealmaking globally. Based in Los Angeles, Jon will lead the firm's efforts across digital media, entertainment tech and related ecosystems. Jon joins Arcadia Capital with more than 15 years of experience in st.
Nebius Group N.V. NBIS and C3.ai, Inc. AI are capitalizing on the rapid adoption of AI, but they are pursuing distinct growth strategies to capture the expanding market opportunity.
C3.ai is positioned as a distressed, event-driven turnaround with a base case fair value of $10, ~12% above current levels. Federal segment bookings are compounding rapidly, the partner pipeline is strong, and expenses have been restructured, providing a credible path to stabilization. The thesis hinges on gross margin recovery, sustained federal growth, and flat opex, with Q1 FY2027 as the critical catalyst for validation.
CEO Thomas Siebel executed the sale of 462,565 shares for ~$4.2 million at a weighted average price of $9.18 per share. The disposition reduced the executive's direct equity position by 39%.
In the closing of the recent trading day, C3.ai, Inc. (AI) stood at $8.91, denoting a -2.52% move from the preceding trading day.
SEC filings for AI aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.